Nuffield Orthopaedic Centre, Windmill Road, Headington, Oxfordshire, England, UK.
Christchurch School of Medicine, University of Otago, Christchurch, New Zealand.
Eur Spine J. 2018 Sep;27(9):2062-2071. doi: 10.1007/s00586-018-5590-4. Epub 2018 Apr 19.
To analyse the complication profile of magnetically controlled growing rods (MCGRs) in early onset scoliosis (EOS).
This is a systematic review using PUBMED, Medline, Embase, Google Scholar and the Cochrane Library (keywords: MAGEC, Magnetically controlled growing rods and EOS) of all studies written in English with a minimum of five patients and a 1-year follow-up. We evaluated coronal correction, growth progression (T1-S1, T1-T12) and complications.
Fifteen studies (336 patients) were included (42.5% male, mean age 7.9 years, average follow-up 29.7 months). Coronal improvement was achieved in all studies (pre-operative 64.8°, latest follow-up 34.9° p = 0.000), as was growth progression (p = 0.001). Mean complication rate was 44.5%, excluding the 50.8% medical complication rate. The unplanned revision rate was 33%. The most common complications were anchor pull-out (11.8%), implant failure (11.7%) and rod breakage (10.6%). There was no significant difference between primary (39.8%) and conversion (33.3%) procedures (p = 0.462). There was a non-statistically significant increased complication rate with single rods (40 vs. 27% p = 0.588).
MCGRs improve coronal deformity and maintain spinal growth, but carry a 44.5% complication and 33% unplanned revision rate. Conversion procedures do not increase this risk. Single rods should be avoided. These slides can be retrieved under Electronic Supplementary material.
分析早期发病脊柱侧凸(EOS)中磁控生长棒(MCGR)的并发症谱。
这是一项系统评价,使用 PUBMED、Medline、Embase、Google Scholar 和 Cochrane Library(关键词:MAGEC、磁控生长棒和 EOS)检索所有英文文献,纳入至少有 5 名患者且随访时间至少 1 年的研究。我们评估了冠状面矫正、生长进展(T1-S1、T1-T12)和并发症。
纳入了 15 项研究(336 名患者)(42.5%为男性,平均年龄 7.9 岁,平均随访时间 29.7 个月)。所有研究均获得冠状面改善(术前 64.8°,末次随访 34.9°,p=0.000)和生长进展(p=0.001)。总的并发症发生率为 44.5%,不包括 50.8%的医疗并发症发生率。计划性翻修率为 33%。最常见的并发症是锚钉拔出(11.8%)、植入物失败(11.7%)和棒断裂(10.6%)。初次手术(39.8%)和翻修手术(33.3%)的并发症发生率无显著差异(p=0.462)。单棒组(40%)与双棒组(27%)的并发症发生率无统计学差异(p=0.588)。
MCGR 可改善冠状面畸形并维持脊柱生长,但并发症发生率为 44.5%,计划性翻修率为 33%。翻修手术不会增加这一风险。应避免使用单棒。这些幻灯片可以在电子补充材料中找到。